Health
Absence of anti-tumor protein may cause resistance to EGFR-targeting therapies – News-Medical.Net
The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College…
The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers. They said that testing cancers for the presence of this protein may help clinicians identify patients who may be resistant to or relapse when treated with the therapy.
Epidermal growth factor receptor (EGFR) is a protein that plays a role in cell division and survival signaling and is active in skin, bladder,…
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Business8 hours agoWhere next for the CBA share price?
-
General22 hours agoRed tape on chopping block in bid to build homes faster